Company Profile
Outlook Stock Price, News & Analysis
- Ticker:
- OTLK
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
1.38 USD (+69.62%)
Close
Last updated: July 20, 2026
121M USD
Market cap
Why the stock is moving
OTLK is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Outlook is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Outlook is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Outlook follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Outlook sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
- 02
Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA
BMY · Source: BMYBristol-Myers Squibb Company
- 03
- 04
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy
FMS · Source: Fresenius Medical Care Ventures
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Outlook (OTLK)?
Outlook (OTLK) most recently closed at 1.38 USD, a +69.62% move versus the previous session.
What is the market cap of Outlook (OTLK)?
Outlook currently has a market capitalization of 121M USD on BioPharmSignal.
What does Outlook do?
Outlook is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is OTLK stock listed?
Outlook (OTLK) is associated with NASDAQ, United States, Biotechnology.
What is Outlook?
Outlook is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Outlook targeting with Outlook?
Outlook is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.